JILL FUHRMANN: Open Payments
NPI 1952535098 · GAINESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 27 payments from 12 companies in 2025. Trend: 2023 $233 · 2024 $261 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $184 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Astellas Pharma US Inc | 2 | $58 |
| Abbott Laboratories | 2 | $43 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $40 |
| Novo Nordisk Inc | 1 | $30 |
| OWP Pharmaceuticals, Inc. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
Products named: VRAYLAR, Veozah, AIRSUPRA, NEFFY, ETERNA, Subvenite, XYOSTED, PAXLOVID.
Industry payments across TX — which companies pay providers there.
